Anhui Fengyuan Pharmaceutical Co., Ltd.

Financial

[
  {
    "link": "quarterly",
    "btn_text": "All Quarterly Results",
    "header": "Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -11.15% vs -16.05% in Mar 2025",
        "dir": 1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in quarter ended Mar 2026 is -2.41% vs -19.61% in Mar 2025",
        "dir": 1
      }
    ],
    "table": {
      "header": [
        "Mar'26",
        "Mar'25",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "835.90",
          "val2": "940.80",
          "chgp": "-11.15%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "43.30",
          "val2": "85.30",
          "chgp": "-49.24%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "7.30",
          "val2": "8.30",
          "chgp": "-12.05%",
          "chgp_class": "positive"
        },
        {
          "field": "Exceptional Items",
          "val1": "-0.10",
          "val2": "-4.30",
          "chgp": "97.67%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "36.40",
          "val2": "37.30",
          "chgp": "-2.41%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "51.80%",
          "val2": "48.00%",
          "chgp": "0.38%",
          "chgp_class": "positive"
        }
      ]
    }
  },
  {
    "link": "annual",
    "btn_text": "All Annual Results",
    "header": "Annual Results Snapshot (Consolidated) - Dec'25",
    "rhs": [
      {
        "prefix": "Net Sales ",
        "suffix": "YoY Growth in year ended Dec 2025 is -9.50% vs 0.30% in Dec 2024",
        "dir": -1
      },
      {
        "prefix": "Consolidated Net Profit ",
        "suffix": "YoY Growth in year ended Dec 2025 is -39.89% vs 0.25% in Dec 2024",
        "dir": -1
      }
    ],
    "table": {
      "header": [
        "Dec'25",
        "Dec'24",
        "Change(%)"
      ],
      "body": [
        {
          "field": "Net Sales",
          "val1": "3,846.70",
          "val2": "4,250.70",
          "chgp": "-9.50%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit (PBDIT) excl Other Income",
          "val1": "284.00",
          "val2": "323.00",
          "chgp": "-12.07%",
          "chgp_class": "negative"
        },
        {
          "field": "Interest",
          "val1": "35.70",
          "val2": "31.30",
          "chgp": "14.06%",
          "chgp_class": "negative"
        },
        {
          "field": "Exceptional Items",
          "val1": "-2.70",
          "val2": "-5.30",
          "chgp": "49.06%",
          "chgp_class": "positive"
        },
        {
          "field": "Consolidate Net Profit",
          "val1": "94.80",
          "val2": "157.70",
          "chgp": "-39.89%",
          "chgp_class": "negative"
        },
        {
          "field": "Operating Profit Margin (Excl OI)",
          "val1": "31.90%",
          "val2": "42.50%",
          "chgp": "-1.06%",
          "chgp_class": "negative"
        }
      ]
    }
  }
]

Quarterly Results Snapshot (Consolidated) - Mar'26 - YoY

Mar'26

Mar'25

Change(%)

Net Sales

835.90

940.80

-11.15%

Operating Profit (PBDIT) excl Other Income

43.30

85.30

-49.24%

Interest

7.30

8.30

-12.05%

Exceptional Items

-0.10

-4.30

97.67%

Consolidate Net Profit

36.40

37.30

-2.41%

Operating Profit Margin (Excl OI)

51.80%

48.00%

0.38%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in quarter ended Mar 2026 is -11.15% vs -16.05% in Mar 2025

Consolidated Net Profit

YoY Growth in quarter ended Mar 2026 is -2.41% vs -19.61% in Mar 2025

All Quarterly Results

Annual Results Snapshot (Consolidated) - Dec'25

Dec'25

Dec'24

Change(%)

Net Sales

3,846.70

4,250.70

-9.50%

Operating Profit (PBDIT) excl Other Income

284.00

323.00

-12.07%

Interest

35.70

31.30

14.06%

Exceptional Items

-2.70

-5.30

49.06%

Consolidate Net Profit

94.80

157.70

-39.89%

Operating Profit Margin (Excl OI)

31.90%

42.50%

-1.06%

USD in Million.

Compare with Peers

Net Sales

YoY Growth in year ended Dec 2025 is -9.50% vs 0.30% in Dec 2024

Consolidated Net Profit

YoY Growth in year ended Dec 2025 is -39.89% vs 0.25% in Dec 2024

All Annual Results